Job was saved successfully.
Job was removed from Saved Jobs.

Job Details


Director, Global Prostate Cancer



Full Time

On Site


East Hanover, New Jersey, United States

Job Description

AAA Statement :
Advanced Accelerator Applications, a Novartis company, is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging. We are committed to transforming patients’ lives by leading innovation in nuclear medicine.
AAA offers professionals the opportunity to face new challenges and pursue a career in a fast growing, technology driven healthcare company. We are passionate about improving patient health by leading innovation in nuclear medicine. We are looking for people who share our commitment to help us achieve this goal. Advanced Accelerator Applications is an Equal Opportunity Employer (EOE).
Job Description :

Global Prostate Cancer Strategy Director will be accountable for contributing to developing overall, cross-functional programs of a priority disease area, especially early in lifecycle – focused on shaping assets with strong commercial potential in line with RLT priorities. The role provides direction and functional expertise in a cross-functional Prostate Cancer team and prioritizes US first with enhanced focus on major markets (e.g., China, Japan, Germany) and ensure close collaboration with Strategy and Early Product, NIBR, GDD and MAP teams.


1. Prostate Cancer strategy aligned with RLT strategy
Collaborating to ensure definition and execution of a competitive strategy to establish Novartis as true industry leader within the Prostate Cancer and maximize patient impact by influencing/ partnering across the disease ecosystem.
• Contribute to defining Prostate Cancer aspirations, goals, and priorities or across the assets within Prostate Cancer, supporting strategic cross- Prostate Cancer -brand alignments to continuously ensure speaking with one voice to the wider organization
• Support key stakeholders (Global Prostate Cancer Head, RLT Strategy & Early Portfolio Team, IM-US, IMI major markets, MAP team, NIBR & GDD) with early commercial evaluations of assets, particularly at development decision points, bringing deep prostate cancer expertise and commercial acumen; in particular, supporting the assets not reaching Innovative Medicine’s strategy, enterprise value criteria or prostate cancer strategy are closed out swiftly
• Contribute to the development of robust forecasts
• Define light-touch (prostate cancer-specific) above-country Health Systems & Policy strategy (objectives, priorities)

2. Asset shaping
Shaping market-relevant assets to become Standard of Care with a focus on US
• Collaborate to develop transformative, US-centric Target Product Profiles (TPPs) that are tangible, provide a clear guidance to the GDD organization on what level of evidence is required.
• Make data-driven, decisive tradeoffs between needs of US and major markets (e.g., CN, JP, DE)
• Bring a deep understanding of customer needs and healthcare ecosystems in priority markets and innovative customer value management approaches to guide development programs
• Co-develop and execute integrated Evidence Plan (IEP) with input into GDD trial design - bringing a credible, aligned commercial perspective to maximize commercialization/patient access potential

3. Integrated early brand strategies
• Collaborate to ensure impactful, actionable early brand strategies until handover to International
• Co-develop Integrated Insights Plan, consolidating and aligning inputs and requirements across functions to achieve deep prostate cancer ecosystem understanding (patient journey, competitive, access landscape, HCS budget impact and cost effectiveness analysis)
• Co-develop early Integrated Product Strategy (IPS) rooted in customer/ market centricity (until handover to International)
• Collaborate to define early medical affairs strategy as part IPS, incl. scientific platform/core claims, disease awareness, medical expert engagement, etc.
• Collaborate to ensure delivery of the early access, reimbursement, and pricing strategies (early Integrated Product Access Strategy) to shape value proposition for HCP / payer / patients / HCS
• Contribute to cross-functionally aligned stakeholder mapping/ prioritization and engagement plan

4. Brand management across the lifecycle
Accountable for maintaining the integrity, consistency, and evolution of each brand across the lifecycle
• Co-develop and maintain an impactful brand identity, positioning, aligning across commercial, medical requirements for global brand consistency
• Co-develop and maintain a pricing strategy framework/ link for global price cross-referencing
• Collectively define and coordinate lifecycle management (LCM) strategy (incl. indications strategy/ sequencing, formulations, connected devices, combinations, follow-on assets)

5. Collaboration
Successfully working within a cross-functional prostate cancer team to achieve goals
• Work in a diverse, high performance, cross-functionally matrixed team including identifying and integrating expertise and inputs required from other teams to ensure successful delivery (e.g., MAP)
• Bring in functional expertise in cross-functional areas (commercial, medical, market access, development, finance) to ensure appropriate focus dedicated to assets
• Ensure appropriate compliance against company policies and procedures